UPDATE: Evercore ISI Upgrades Akero Therapeutics (AKRO) to Outperform, PT $50
Tweet Send to a Friend
(Updated - September 13, 2022 7:13 PM EDT)
Evercore ISI analyst Josh Schimmer upgraded Akero Therapeutics (NASDAQ: AKRO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Evercore ISI analyst Josh Schimmer upgraded Akero Therapeutics (NASDAQ: AKRO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
